To include your compound in the COVID-19 Resource Center, submit it here.

CureXcell: Completed Phase III enrollment

Macrocure completed enrollment of 280 patients with diabetic foot ulcers in a double-blind, sham-controlled, international Phase III trial evaluating

Read the full 191 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE